Molecular epidemiology of HIV-1 in Switzerland: Evidence for a silent mutation in the C2V3 region distinguishing intravenous drug users from homosexual men

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 23, Issue 1, 2000, Pages 58-67

  Stoeckli, Thomas C ^a,c   Steffen Klopfstein, Ingrid ^b   Erb, Peter ^b   Brown, Teresa M ^a   Kalish, Marcia L ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; Molecular epidemiology; Switzerland

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; EPIDEMIC; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SILENT GENE; SWITZERLAND;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034087628     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200001010-00008     Document Type: Article

References (35)

1. Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, Pavlakis GN. Human retroviruses and AIDS 1994: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, 1995.
2. Simon F, Mauclère P, Roques P, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and O. Nat Med 1998;4:1032-7.
3. De Leys R, Vanderborght B, van den Haesevelde M, et al. Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin. J Virol 1990;64:1207-16.
4. Gurtler LG, Hauser PH, Eberle J, et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994;68:1581-5.
5. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1. Nature 1995;374:124-6.
6. Sharp PM, Bailes E, Stevenson M, Emerman M, Hahn BH. Gene acquisition in HIV and SIV. Nature 1996;383:586-7.
7. Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
8. Arnold C, Barlow KL, Parry JV, Clewley JP. At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England. AIDS Res Hum Retroviruses 1995;11:999-1001.
9. Fransen K, Buvé A, Nkengasong JN, Laga M, van der Groen G. Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 1996;347:1403.
10. Simon F, Loussert-Ajaka I, Damont F, Saragosti S, Barin F, BrunVezinet F. HIV type 1 diversity in northern Paris, France. AIDS Res Hum Retroviruses 1996;12:1427-33.
11. Kostrikis LG, Bagdades E, Cao Y, Zhang L, Dimitriou D, Ho DD. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I. J Virol 1995;69:6122-30.
12. Schüpbach J, Haller O, Vogt M, et al. Antibodies to HTLV-III in Swiss patients with AIDS and Pre-AIDS and in risk groups for AIDS. N Engl J Med 1985;312:265-70.
13. Stroun J, Graf I, Frei PC. Detection of anti-HTLV-HI/LAV antibody by enzyme-linked immunosorbent assay in high-risk individuals in Switzerland 1974-85. Eur J Clin Microbiol 1985;4: 583-6.
14. Bundesamt für Gesundheit, Abteilung Epidemiologie und Infektionskrankheiten. AIDS und HIV in der Schweiz. Epidemiologische Situation Ende 1997. Berne, Switzerland: Bundesamt für Gesundheit, Abteilung Epidemiologie und Infektionskrankheiten, 1998.
15. Antonioli IM, Baumberger C, Yely S, Perrin L. V3 sequences in primary HIV-1 infection. AIDS 1995;9:11-17.
16. Deiss V, von Overbeck J, Furrer H-J, Germann D, Matter L, Telenti A. Die Epidemiologie der HIV-1-Infektion in Bern-Anwendung molekularer Methoden. Schweiz Med Wochenschr 1994;124:539-44.
17. Böni J, Pyra H, Gebhardt M, et al. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. JAIDS J Acquir Immune Defi Syndr 1999;22:174-9.
18. Rogers MF, Ou C-Y, Rayfield M, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. N Engl J Med 1989;320:1649-54.
19. Schochetman G, Subbarao S, Kalish ML. Methods for studying genetic variation of the human Immunodeficiency virus (HIV). Viral Genome Methods. In: Adolph KW (ed). Viral genome methods. Boca Raton, FL: CRC Press, 1996:25-41.
20. Cabot EL, Beckenbach AT. Simultaneous editing of multiple nucleic acid and protein sequences with ESEE. Comp Appl Biosci 1989;5:233-4.
21. The Wisconsin Package, version 9. Madison, WI: Genetics Computer Group, 1996.
22. Felsenstein, J. PHYLIP: Phylogeny inference package, versions 3.5c and 4.0. Seattle, WA: University of Washington, 1993.
23. Page RDM. Treeview: an application to display phylogenetic trees on personal computers. Comp Appl Biosci 1996;12:357-8.
24. La Rosa GJ, Davide JP, Weinhold K, et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 1990;249:932-5.
25. Morgado MG, Sabino EC, Shpaer EG, et al. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses 1994;10:569-76.
26. Potts KE, Kalish ML, Lott T, et al. Genetic heterogeneity of the V3 region of the HIV-1 envelope glycoprotein in Brazil. AIDS 1991; 7:1191-7.
27. Robbins KE, Kostrikis LG, Brown TM, et al. Genetic analysis of human immunodeficiency virus type 1 strains in Kenya: a comparison using phylogenetic analysis and a combinatorial melting assay. AIDS Res Hum Retroviruses 1999;15:329-35.
28. Orloff GM, Kalish ML, Chiphangwi J, et al. V3 loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site. AIDS Res Hum Retroviruses 1993;9:705-6.
29. Potts KE, Kalish ML, Bandea C, et al. Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire. AIDS Res Hum Retroviruses 1993;9:613-8.
30. McCutchan FE, Sanders-Buell E, Carr JK, et al. Multiple forms of inter-subtype recombinant human immunodeficiency virus type 1 (HIV-1) in Nigeria. Virology 1999;254:226-234.
31. Subbarao S, Limpakarnjanarat K, Mastro TD, et al. HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. AIDS Res Hum Retroviruses 1998;14:319-27.
32. Dumitrescu O, Kalish ML, Kliks SC, Bandea C, Levy JA. Characterization of HIV-1 strains isolated from children in Romania: identification of a new envelope subtype. J Infect Dis 1994;169: 182-8.
33. Freeman RC, Rodriguez GM, French JF. Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issue. AIDS Educ Prev 1996;8:58-71.
34. Lukashov VV, Kuiken CL, Vlahov D, Coutinho RA, Goudsmit J. Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in Northern Europe. AIDS Res Hum Retroviruses 1996;12:1179-83.
35. Kuiken CL, Goudsmit J. Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe. AIDS Res Hum Retroviruses 1994;10:319-20.